BR112012020828A2 - preparado farmacêutico que contém miramistina - Google Patents

preparado farmacêutico que contém miramistina

Info

Publication number
BR112012020828A2
BR112012020828A2 BR112012020828A BR112012020828A BR112012020828A2 BR 112012020828 A2 BR112012020828 A2 BR 112012020828A2 BR 112012020828 A BR112012020828 A BR 112012020828A BR 112012020828 A BR112012020828 A BR 112012020828A BR 112012020828 A2 BR112012020828 A2 BR 112012020828A2
Authority
BR
Brazil
Prior art keywords
miramistin
pharmaceutical preparation
preparation containing
myristoylamino
propyl
Prior art date
Application number
BR112012020828A
Other languages
English (en)
Other versions
BR112012020828B1 (pt
Inventor
Adolina Rudko
Original Assignee
Megainpharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Megainpharm Gmbh filed Critical Megainpharm Gmbh
Publication of BR112012020828A2 publication Critical patent/BR112012020828A2/pt
Publication of BR112012020828B1 publication Critical patent/BR112012020828B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/131—Amines acyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0046—Ear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Ophthalmology & Optometry (AREA)
  • Virology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

preparado farmacêutico que contém miramistina. a presente inenção se refere a um medicamento contendo cloreto de benzidimetil (3-[miristoilamino]-propil)-amônio na forma monohidratada ou na forma anidra. o medicamento ainda compreende óxido de dimetil(3-[miristoilamino]-propil)-amônio e/ou dimetil(3-[miristoilamino]-propil)-amina em um solvente farmaceuticamente aceitável.
BR112012020828-4A 2010-02-19 2011-02-15 preparado farmacêutico que contém miramistina e seu uso BR112012020828B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
WOPCT/EP2010/001056 2010-02-19
PCT/EP2010/001056 WO2011100994A1 (de) 2010-02-19 2010-02-19 Arzneimittel enthaltend myramistin
PCT/EP2011/000691 WO2011101113A1 (de) 2010-02-19 2011-02-15 Arzneimittel enthaltend myramistin

Publications (2)

Publication Number Publication Date
BR112012020828A2 true BR112012020828A2 (pt) 2016-06-28
BR112012020828B1 BR112012020828B1 (pt) 2021-01-12

Family

ID=42668884

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012020828-4A BR112012020828B1 (pt) 2010-02-19 2011-02-15 preparado farmacêutico que contém miramistina e seu uso

Country Status (21)

Country Link
EP (1) EP2536400B1 (pt)
JP (1) JP5746224B2 (pt)
KR (1) KR101744895B1 (pt)
CN (1) CN102869354B (pt)
AU (1) AU2011217530B2 (pt)
BR (1) BR112012020828B1 (pt)
CY (1) CY1115833T1 (pt)
DK (1) DK2536400T3 (pt)
EA (1) EA022283B1 (pt)
ES (1) ES2524379T3 (pt)
GE (1) GEP20135942B (pt)
HK (1) HK1179164A1 (pt)
HR (1) HRP20141173T1 (pt)
IL (1) IL221501A (pt)
MD (1) MD4411C1 (pt)
MX (1) MX2012009646A (pt)
PL (1) PL2536400T3 (pt)
PT (1) PT2536400E (pt)
SI (1) SI2536400T1 (pt)
UA (1) UA103968C2 (pt)
WO (2) WO2011100994A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014175757A1 (ru) * 2013-04-22 2014-10-30 Общество с ограниченной ответственностью "Нанобиотех" Антисептический ветеринарный препарат и способы его использования
RU2542376C1 (ru) * 2013-07-30 2015-02-20 Государственное бюджетное образовательное учреждение высшего профессионального образования "Курский государственный медицинский университет" Министерства здравоохранения Российской Федерации Средство для лечения гнойно-воспалительных процессов мягких тканей и слизистых оболочек
CN109456218A (zh) * 2018-12-17 2019-03-12 山东诚汇双达药业有限公司 一种盐酸三甲卡因的生产方法

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2459062A (en) 1944-02-08 1949-01-11 American Cyanamid Co Quaternary ammonium compounds
US4093711A (en) * 1976-08-13 1978-06-06 Noxell Corporation Oral hygiene
SU1796185A1 (ru) 1990-06-23 1993-02-23 Adolina P Rudko Фунгицид 2
AU2493792A (en) 1991-07-10 1993-02-11 Jury Semenovich Krivoshein Pharmaceutical preparation
US5393491A (en) 1993-09-22 1995-02-28 Alcon Laboratories, Inc. Use of amidoamines in ophthalmic compositions
UA30143C2 (uk) * 1997-12-30 2001-11-15 Юрій Семенович Кривошеін Лікувальний препарат для профілактики та лікування інфекційних та запальних захворювань
RU2157214C2 (ru) 1998-04-16 2000-10-10 Государственный научный центр лекарственных средств Противовоспалительное и антимикробное лекарственное средство для местного применения
RU2161961C1 (ru) 2000-03-17 2001-01-20 Кривошеин Юрий Семенович Лекарственный препарат
RU2177314C2 (ru) 2000-03-22 2001-12-27 Кривошеин Юрий Семенович Состав с антисептическими, репаративными и болеутоляющими свойствами
RU2173142C1 (ru) 2000-04-18 2001-09-10 Кривошеин Юрий Семенович Вагинальный контрацептив
RU2184534C2 (ru) 2000-04-27 2002-07-10 Рудько Адолина Петровна Антисептические таблетки
RU2164135C1 (ru) 2000-04-27 2001-03-20 Рудько Адолина Петровна Глазной антисептик
RU2185156C2 (ru) 2000-06-26 2002-07-20 Рудько Адолина Петровна Интраназальный антисептик
RU2185157C2 (ru) 2000-06-26 2002-07-20 Рудько Адолина Петровна Средство для лечения ожоговых ран
RU2188005C2 (ru) 2000-10-04 2002-08-27 Рудько Адолина Петровна Состав для антисептической обработки кожи рук и операционного поля
AU2002228660A1 (en) 2000-12-20 2002-07-01 Alcon, Inc Use of amidoamines to treat or prevent acanthamoeba and fungal infections
AU2002226926A1 (en) * 2000-12-20 2002-07-01 Alcon, Inc. Antifungal compositions containing an antibiotic and one or more amidoamines
US20040033208A1 (en) 2000-12-20 2004-02-19 Cagle Gerald D. Antifungal compositions containing an antibiotic and one or more amidoamines
RU2234313C1 (ru) * 2003-06-04 2004-08-20 Кривошеин Юрий Семенович Средство инактивации коронавирусов
RU2005100533A (ru) * 2005-01-13 2006-06-20 Открытое акционерное общество "Система-Венчур" (ОАО "Система-Венчур") (RU) Средство для ускорения заживления раны
US20070264226A1 (en) 2006-05-10 2007-11-15 Karagoezian Hampar L Synergistically enhanced disinfecting solutions
CN101562971A (zh) * 2006-05-10 2009-10-21 S.K.药物公司 协同增强的消毒溶液
CN101100432B (zh) * 2006-07-04 2010-08-04 中国人民解放军军事医学科学院毒物药物研究所 苯甲基二甲基[3-(肉豆蔻酰胺基)丙基]氯化铵的合成方法
DE102008039234A1 (de) * 2007-10-29 2009-05-07 Neudecker & Jolitz Gmbh & Co. Motorisch betriebener Türöffner und Motor für einen Türöffner
UA30143U (en) 2007-11-14 2008-02-11 Валерий Михайлович Шарапов Piezoelectric transformer
DE102008039254A1 (de) * 2008-08-20 2010-02-25 Megainpharm Gmbh Arzneimittel

Also Published As

Publication number Publication date
HK1179164A1 (zh) 2013-09-27
MX2012009646A (es) 2013-02-11
MD4411C1 (ro) 2016-11-30
CN102869354B (zh) 2015-12-16
JP2013519695A (ja) 2013-05-30
KR20130018242A (ko) 2013-02-20
MD4411B1 (ro) 2016-04-30
KR101744895B1 (ko) 2017-06-08
DK2536400T3 (en) 2014-12-15
EA022283B1 (ru) 2015-12-30
EP2536400A1 (de) 2012-12-26
MD20120079A2 (en) 2013-01-31
EA201201158A1 (ru) 2013-02-28
BR112012020828B1 (pt) 2021-01-12
GEP20135942B (en) 2013-10-10
CY1115833T1 (el) 2017-01-25
HRP20141173T1 (hr) 2015-01-30
WO2011100994A1 (de) 2011-08-25
EP2536400B1 (de) 2014-09-24
AU2011217530A1 (en) 2012-09-13
JP5746224B2 (ja) 2015-07-08
AU2011217530B2 (en) 2014-01-16
ES2524379T3 (es) 2014-12-05
IL221501A (en) 2016-11-30
UA103968C2 (ru) 2013-12-10
PL2536400T3 (pl) 2015-04-30
WO2011101113A1 (de) 2011-08-25
PT2536400E (pt) 2014-11-27
SI2536400T1 (sl) 2015-01-30
CN102869354A (zh) 2013-01-09

Similar Documents

Publication Publication Date Title
SMT201700010B (it) Composizioni farmaceutiche comprendenti un anestetico locale come bupivacaina per somministrazione locale alla bocca o alla gola
BR112015009228A2 (pt) soluções estáveis anti-inflamatórias e midriáticas livres de conservantes para injeção
MX2015000813A (es) Composiciones liposómicas de inhibidores de proteasoma basadas en epoxicetona.
BR112014026828A2 (pt) compostos de triazolo como inibidores de pde10
WO2011140203A3 (en) Stabilized ophthalmic galactomannan formulations
BR112014004522A2 (pt) moduladores de pde10
BR112015012825A2 (pt) piridopirazinas substituídas como inibidores de syk
CO6920289A2 (es) Composición farmacéutica oftalmológica tópica que contiene regorafenib.
BR112013018290A2 (pt) antagonistas de receptor 2 ativado por protease (par2)
BR112014028006A2 (pt) heterociclos de pirrolidino
CO6592109A2 (es) Nueva forma cristalina de un derivado de ciclopropilbenzamida
TN2014000060A1 (en) Benzothiazolone compound
BR112014001425A2 (pt) forma de dosagem farmacêutica, composição farmacêutica, e, composto (i) ou sal farmaceuticamente aceitável do mesmo
BR112012020828A2 (pt) preparado farmacêutico que contém miramistina
BR112015014078A2 (pt) composição farmacêutica oftalmológica tópica que contém regorefenib
FR2973707B1 (fr) Dispositif interchangeable d'administration d'une solution medicamenteuse de chimiotherapie
CL2014000489A1 (es) Forma de cristal anhidra de rilapladib, forma 3; composicion farmaceutica que lo comprende; combinacion farmaceutica; su uso en el tratamiento de la enfermedad de alzheimer.
PL395069A1 (pl) Przeciwbólowa kompozycja farmaceutyczna do podawania doustnego
IL238072B (en) Use of 1-adamantylethyloxy-3-morpholino-2-propanol or pharmaceutically acceptable salts thereof in pharmaceutical compositions as a neuroretinal protector
IN2013MN01164A (pt)
UA23456S (uk) Розгортка упаковки для засобу «aquallen»
UA23458S (uk) Розгортка упаковки для засобу «aquafill»
UA23459S (uk) Розгортка упаковки для засобу «aqualin»
UA23460S (uk) Розгортка упаковки для засобу «aqualind»
UA23457S (uk) Розгортка упаковки для засобу «aqualift»

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06T Formal requirements before examination [chapter 6.20 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 15/02/2011, OBSERVADAS AS CONDICOES LEGAIS.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 13A ANUIDADE.

B21H Decision of lapse of a patent or of a certificate of addition of invention cancelled [chapter 21.8 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 21.6 NA RPI NO 2762 DE 12/12/2023 POR TER SIDO INDEVIDA.